NYSE:IH - iHuman Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $26.10
  • Forecasted Upside: 151.93 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$10.36
▲ +0.18 (1.77%)
1 month | 3 months | 12 months
Get New iHuman Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IH

Average Price Target: $26.10
▲ +151.93% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for iHuman in the last 3 months. The average price target is $26.10, with a high forecast of $26.10 and a low forecast of $26.10. The average price target represents a 151.93% upside from the last price of $10.36.

Buy

The current consensus among 1 investment analysts is to buy stock in iHuman.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/19/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/24/2020National SecuritiesInitiated CoverageBuy$26.10N/A
(Data available from 6/18/2016 forward)

iHuman

iHuman Inc. provides childhood edutainment products and services to individual users, education organizations, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Magic Math, iHuman Books, and iHuman Stories. It also provides learning materials in physical and digital formats; and learning devices. The company was founded in 1996 and is based in Beijing, the People's Republic of China.
Read More

Today's Range

Now: $10.36
Low: $9.85
High: $10.65

50 Day Range

MA: $10.93
Low: $8.96
High: $14.05

52 Week Range

Now: $10.36
Low: $8.94
High: $31.58

Volume

10,801 shs

Average Volume

89,471 shs

Market Capitalization

$552.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of iHuman?

The following sell-side analysts have issued stock ratings on iHuman in the last twelve months: National Securities.
View the latest analyst ratings for IH.

What is the current price target for iHuman?

1 Wall Street analysts have set twelve-month price targets for iHuman in the last year. Their average twelve-month price target is $26.10, suggesting a possible upside of 151.9%. National Securities has the highest price target set, predicting IH will reach $26.10 in the next twelve months. National Securities has the lowest price target set, forecasting a price of $26.10 for iHuman in the next year.
View the latest price targets for IH.

What is the current consensus analyst rating for iHuman?

iHuman currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IH will outperform the market and that investors should add to their positions of iHuman.
View the latest ratings for IH.

What other companies compete with iHuman?

How do I contact iHuman's investor relations team?

The company's listed phone number is 86 10 5780 6606 and its investor relations email address is [email protected] The official website for iHuman is www.ihuman.com.